Effect of Total Plasma Homocysteine on Cervical Dysplasia Risk

• Published in: Nutrition and cancer 2000-01, Vol.37 (2), p.128-133
• Main Authors: Thomson, Stephen W., Heimburger, Douglas C., Cornwell, Phillip E., Turner, Malcolm E., Sauberlich, Howerde E., Fox, Liesl M., Butterworth, Charles E.
• Format: Article
• Language: English
• Subjects: Adult; Biological and medical sciences; Biomarkers; Case-Control Studies; Cervical Intraepithelial Neoplasia - blood; Cervical Intraepithelial Neoplasia - etiology; Contraceptives, Oral - adverse effects; Female; Female genital diseases; Folic Acid - blood; Folic Acid Deficiency - complications; Folic Acid Deficiency - diagnosis; Gynecology. Andrology. Obstetrics; Homocysteine - blood; Humans; Medical sciences; Papillomaviridae - isolation & purification; Papillomavirus Infections - complications; Parity; Risk Factors; Smoking - adverse effects; Tumor Virus Infections - complications; Tumors; Uterine Cervical Neoplasms - blood; Uterine Cervical Neoplasms - etiology
• ISSN: 0163-5581; 1532-7914
• DOI: 10.1207/S15327914NC372_2

We investigated whether total plasma homocysteine (tHcy) is associated with risk for cervical intraepithelial neoplasia (CIN). tHcy was evaluated, along with numerous risk factors for CIN and biochemical indexes of nutrients, in a previously reported study population of 294 subjects with CIN and 170 female controls without CIN. tHcy was significantly higher in cases than in controls (9.1 vs. 8.3 μmol/l, p = 0.002). Human papillomavirus type 16 infection [odds ratio (OR) = 6.7], oral contraceptive use (OR = 6.0), parity (OR = 2.2), and cigarette smoking (OR = 1.9) were significantly associated with CIN after adjustment for each other and for age, number of sexual partners, and plasma tHcy, folate, iron, and zinc. Human papillomavirus type 16 positivity increased risk for CIN more when tHcy was >9.12 μmol/l (OR = 4.7) than when it was ≤9.12 μmol/l (OR = 3.0). Cigarette use increased risk for CIN when tHcy was >9.12 μmol/l (OR = 3.9), but not when tHcy was ≤9.12 μmol/l (OR = 1.5). Parity increased risk for CIN more when tHcy was >9.12 μmol/l (OR = 4.0) than when tHcy was ≤9.12 μmol/l (OR = 2.0). These results suggest that elevated plasma tHcy is a risk factor for cervical dysplasia and that it enhances the effects of other risk factors. It is unknown whether tHcy is serving as a marker of folate deficiency or is acting through other mechanisms.